Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
3.740
+0.010 (0.27%)
Feb 24, 2026, 4:00 PM EST - Market closed
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $35.09 million as of February 25, 2026.
Market Cap
35.09M
Enterprise Value
-1.15M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.74
Market Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $35.09M, a decrease of -79.45%. That is a compound annual growth rate of -84.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 34.99M | -13.26% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atossa Therapeutics | 36.25M |
| PDS Biotechnology | 35.46M |
| Palatin Technologies | 35.44M |
| OnKure Therapeutics | 35.23M |
| INmune Bio | 34.83M |
| Outlook Therapeutics | 34.32M |
| Kyntra Bio | 33.66M |
| RenovoRx | 33.45M |